NORTHERN TRUST CORP - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 45 filers reported holding LUMOS PHARMA INC in Q2 2020. The put-call ratio across all filers is 5.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2021$10,000
-41.2%
1,008
-42.6%
0.00%
Q2 2021$17,000
-51.4%
1,756
-40.7%
0.00%
Q1 2021$35,000
-91.9%
2,960
-75.5%
0.00%
Q4 2020$432,000
+904.7%
12,081
+292.0%
0.00%
Q3 2020$43,000
-15.7%
3,082
-0.3%
0.00%
Q2 2020$51,000
+82.1%
3,091
-5.8%
0.00%
Q1 2020$28,0003,2820.00%
Other shareholders
LUMOS PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Minerva Advisors LLC 34,015$321,0000.21%
Lion Point Capital, LP 51,205$481,0000.11%
Wealth Advisors of Iowa, LLC 11,699$110,0000.06%
NEA Management Company, LLC 167,608$1,575,0000.04%
Paladin Advisory Group, LLC 4,382$40,0000.03%
Marquette Asset Management, LLC 13,315$125,0000.03%
Blackstone Inc. 468,145$4,401,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$450,0000.01%
Jefferies Group LLC 120,651$1,134,1190.01%
Renaissance Technologies 271,712$2,554,0000.00%
View complete list of LUMOS PHARMA INC shareholders